Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.
Journal: JAMA network open
Published: February 14, 2025
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26 Weeks Treatment.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 10, 2024
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Journal: Diabetes, obesity & metabolism
Published: December 13, 2023
Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
Journal: Diabetes care
Published: May 17, 2018
Glucokinase mutation-a rare cause of recurrent hypoglycemia in adults: a case report and literature review.
Journal: Journal of community hospital internal medicine perspectives
Published: July 27, 2016
Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: June 24, 2009
Showing 1-6 of 6
Last Updated: 09/26/2026